Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine

Completed · Phase 4

Conditions studied: Male Infertility

In brief

The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.

Key facts

Study ID

NCT03802864

Run by

Weill Medical College of Cornell University

People needed

50

Starts

2019-02-04

Expected to finish

2020-01-30

Last updated by the study team

2020-12-17

Who can join

Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men scheduled for surgical sperm retrieval for infertility
• Men 18 years and older who can provide informed consent
• No documented allergy to bupivacaine or celecoxib

You may not qualify if…

• Prior history of substance abuse
• Any narcotic use within the last 3 months
• Concomitant use of aspirin
• Any of the following comorbidities: renal failure, heart disease, peptic ulcer disease, cerebrovascular disease, significant liver disease, untreated depression, chronic pain disorder, or bleeding diatheses
• Medical history or concurrent illness that the investigator considers sufficiently serious to interfere with the conduct, completion, or results of this trial, or constitutes an unacceptable risk to the subject

Where it is running

• Weill Cornell Medicine Department of Urology — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.